PHARMA
CBMG Acquires Novel T-Cell Therapy Technology
The CAR-T cell therapy developed at the Chinese People's Liberation Army General Hospital uses cancer patient's own immune cells to attack tumors.
MerLion’s Antibiotic Receives US FDA Approval
FDA approval for the otic suspension of finafloxacin paves the way for future Phase III trials for the injectable and oral forms.
BGI Announces Clinical Results Of Prenatal Test
BGI's non-invasive prenatal test (NIFTY®) has shown to be highly sensitive and specific in a trial involving close to 150,000 pregnancies.
Innovent Raises US$100 Million
Supported by the latest round of funding, Innovent will open China's largest internationally certified biologics production facility.
Austrianova Opens New Facilities In Singapore
The Austrianova facility at Synpase, Biopolis will house the company's headquarters and GMP production activities.
BMS Foundation Awards US$3.5 Million In Hepatitis Grants
Bristol-Myers Squibb has awarded US$3.5 million in grants to tackle the 'silent epidemic' of hepatitis in India and China.
Eisai Launches Liver Cirrhosis Drug In The Philippines
The drug for treating liver cirrhosis-associated hypoalbuminemia is also awaiting clinical trials in China.
WuXi PharmaTech Acquires NextCODE For US$65 Million
NextCODE and WuXi's Genome Center will offer comprehensive clinical, research, and diagnostic testing products and services worldwide.
Kyowa Hakko Kirin & Syndax To Develop Tumor Therapy
Entinostat, an epigenetic modification drug, is slated for clinical trials in Japan and Korea in 2015.
